Diet- and microbiota-related metabolite, 5-aminovaleric acid betaine (5-AVAB), in health and disease

dc.contributor.authorHaikonen Retu
dc.contributor.authorKärkkäinen Olli
dc.contributor.authorKoistinen Ville
dc.contributor.authorHanhineva Kati
dc.contributor.organizationfi=elintarviketieteet|en=Food Sciences|
dc.contributor.organization-code1.2.246.10.2458963.20.15178954341
dc.converis.publication-id175509263
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/175509263
dc.date.accessioned2025-08-27T21:28:44Z
dc.date.available2025-08-27T21:28:44Z
dc.description.abstract<p>5-Aminovaleric acid betaine (5-AVAB) is a trimethylated compound associated with the gut microbiota, potentially produced endogenously, and related to the dietary intake of certain foods such as whole grains. 5-AVAB accumulates within the metabolically active tissues and has been typically found in higher concentrations in the heart, muscle, and brown adipose tissue. Furthermore, 5-AVAB has been associated with positive health effects such as fetal brain development, insulin secretion, and reduced cancer risk. However, it also has been linked with some negative health outcomes such as cardiovascular disease and fatty liver disease. At the cellular level, 5-AVAB can influence cellular energy metabolism by reducing β-oxidation of fatty acids. This review will focus on the metabolic role of 5-AVAB with respect to both physiology and pathology. Moreover, the analytics and origin of 5-AVAB and related compounds will be reviewed. © 2022 The Authors</p><h3>Author keywords</h3><p>5-aminovaleric acid betaine (5-AVAB); aminovaleric acid betaine; N,N,N-trimethyl-5-aminovalerate (TMAV); N,N,N-trimethyl-5-aminovaleric acid (TMAVA); δ-valerobetaine (δVB)</p>
dc.format.pagerange463
dc.format.pagerange480
dc.identifier.jour-issn1043-2760
dc.identifier.olddbid200468
dc.identifier.oldhandle10024/183495
dc.identifier.urihttps://www.utupub.fi/handle/11111/46644
dc.identifier.urlhttps://doi.org/10.1016/j.tem.2022.04.004
dc.identifier.urnURN:NBN:fi-fe2022081153789
dc.language.isoen
dc.okm.affiliatedauthorKoistinen, Ville
dc.okm.affiliatedauthorHanhineva, Kati
dc.okm.discipline1182 Biochemistry, cell and molecular biologyen_GB
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3141 Health care scienceen_GB
dc.okm.discipline1182 Biokemia, solu- ja molekyylibiologiafi_FI
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.discipline3141 Terveystiedefi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA2 Scientific Article
dc.publisherElsevier Inc.
dc.publisher.countryNetherlandsen_GB
dc.publisher.countryAlankomaatfi_FI
dc.publisher.country-codeNL
dc.relation.doi10.1016/j.tem.2022.04.004
dc.relation.ispartofjournalTrends in Endocrinology and Metabolism
dc.relation.issue7
dc.relation.volume33
dc.source.identifierhttps://www.utupub.fi/handle/10024/183495
dc.titleDiet- and microbiota-related metabolite, 5-aminovaleric acid betaine (5-AVAB), in health and disease
dc.year.issued2022

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
1-s2.0-S1043276022000613-main.pdf
Size:
2.82 MB
Format:
Adobe Portable Document Format